Latest thinking

Brexit and digital health

10 October 2017

Industries: Life Sciences and Healthcare

As the UK negotiates its new relationship with the European Union, the provision of crossborder healthcare as well as the development and regulation of medical technology pose important questions. Hein van den Bos, Counsel at Hogan Lovells, provides commentary on the objectives of the Brexit negotiations for the UK and the EU, and considers how and why both sides will look to continue collaborating to develop digital health without border restrictions.